BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11259477)

  • 1. The role of presenilins in gamma-secretase activity: catalyst or cofactor?
    Small DH
    J Neurochem; 2001 Mar; 76(6):1612-4. PubMed ID: 11259477
    [No Abstract]   [Full Text] [Related]  

  • 2. Presenilin and gamma-secretase: structure meets function.
    Wolfe MS
    J Neurochem; 2001 Mar; 76(6):1615-20. PubMed ID: 11259478
    [No Abstract]   [Full Text] [Related]  

  • 3. Assembly and activation of the gamma-secretase complex: roles of presenilin cofactors.
    Iwatsubo T
    Mol Psychiatry; 2004 Jan; 9(1):8-10. PubMed ID: 14581930
    [No Abstract]   [Full Text] [Related]  

  • 4. The multiple paradoxes of presenilins.
    Checler F
    J Neurochem; 2001 Mar; 76(6):1621-7. PubMed ID: 11259479
    [No Abstract]   [Full Text] [Related]  

  • 5. gamma-Secretase inhibitors as molecular probes of presenilin function.
    Wolfe MS
    J Mol Neurosci; 2001 Oct; 17(2):199-204. PubMed ID: 11816793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A portrait of Alzheimer secretases--new features and familiar faces.
    Esler WP; Wolfe MS
    Science; 2001 Aug; 293(5534):1449-54. PubMed ID: 11520976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
    Wolfe MS; Xia W; Ostaszewski BL; Diehl TS; Kimberly WT; Selkoe DJ
    Nature; 1999 Apr; 398(6727):513-7. PubMed ID: 10206644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease. Closing in on gamma-secretase.
    De Strooper B
    Nature; 2000 Jun; 405(6787):627, 629. PubMed ID: 10864307
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteolysis by presenilins and the renaissance of tau.
    Haass C; Mandelkow E
    Trends Cell Biol; 1999 Jun; 9(6):241-4. PubMed ID: 10408925
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroscience. An accomplice for gamma-secretase brought into focus.
    Sisodia SS
    Science; 2000 Sep; 289(5488):2296-7. PubMed ID: 11041797
    [No Abstract]   [Full Text] [Related]  

  • 11. Presenilins as therapeutic targets for the treatment of Alzheimer's disease.
    Golde TE; Younkin SG
    Trends Mol Med; 2001 Jun; 7(6):264-9. PubMed ID: 11378516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abeta-generating enzymes: recent advances in beta- and gamma-secretase research.
    Vassar R; Citron M
    Neuron; 2000 Sep; 27(3):419-22. PubMed ID: 11055423
    [No Abstract]   [Full Text] [Related]  

  • 13. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
    Li YM; Xu M; Lai MT; Huang Q; Castro JL; DiMuzio-Mower J; Harrison T; Lellis C; Nadin A; Neduvelil JG; Register RB; Sardana MK; Shearman MS; Smith AL; Shi XP; Yin KC; Shafer JA; Gardell SJ
    Nature; 2000 Jun; 405(6787):689-94. PubMed ID: 10864326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of presenilin-nicastrin complexes and gamma-secretase activity to the trans-Golgi network.
    Siman R; Velji J
    J Neurochem; 2003 Mar; 84(5):1143-53. PubMed ID: 12603837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilins, Alzheimer's disease, and capacitative calcium entry.
    Putney JW
    Neuron; 2000 Sep; 27(3):411-2. PubMed ID: 11055420
    [No Abstract]   [Full Text] [Related]  

  • 16. Presenilin function and gamma-secretase activity.
    Brunkan AL; Goate AM
    J Neurochem; 2005 May; 93(4):769-92. PubMed ID: 15857382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation.
    Herreman A; Van Gassen G; Bentahir M; Nyabi O; Craessaerts K; Mueller U; Annaert W; De Strooper B
    J Cell Sci; 2003 Mar; 116(Pt 6):1127-36. PubMed ID: 12584255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.
    Wolfe MS; De Los Angeles J; Miller DD; Xia W; Selkoe DJ
    Biochemistry; 1999 Aug; 38(35):11223-30. PubMed ID: 10471271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gamma-Secretase: characterization and implication for Alzheimer disease therapy.
    Xu M; Lai MT; Huang Q; DiMuzio-Mower J; Castro JL; Harrison T; Nadin A; Neduvelil JG; Shearman MS; Shafer JA; Gardell SJ; Li YM
    Neurobiol Aging; 2002; 23(6):1023-30. PubMed ID: 12470798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.
    Esler WP; Kimberly WT; Ostaszewski BL; Diehl TS; Moore CL; Tsai JY; Rahmati T; Xia W; Selkoe DJ; Wolfe MS
    Nat Cell Biol; 2000 Jul; 2(7):428-34. PubMed ID: 10878808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.